NCT05604547View on ClinicalTrials.gov

Exploring Near Infrared Spectroscopy (NIRS) Technologies for Assessment of Muscle Physiology, Tissue Oxygenation, and Blood Flow in Patients With Sickle Cell Disease (SCD)

CompletedOBSERVATIONAL
Enrollment

49

Participants

Timeline

Start Date

November 28, 2022

Primary Completion Date

January 24, 2025

Study Completion Date

January 24, 2025

Conditions
SCD
Interventions
DIAGNOSTIC_TEST

Non-Invasive Infrared Spectroscopy

NIRS is a non-Invasive optical technique for characterizing microvascular hemodynamics.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH